R&D Incentives and Market Structure: Dynamic Analysis
نویسندگان
چکیده
منابع مشابه
Bribes vs. Taxes: Market Structure and Incentives∗
Firms in developing countries often avoid paying taxes by making informal payments to business tax inspectors. These bribes increase the cost of operating a business, and the price charged to consumers. To decrease these costs, we designed a feedback incentive scheme for business tax inspectors that rewards them according to the anonymous evaluation submitted by inspected firms. The scheme incr...
متن کاملStorability, Market Structure and Demand-Shift Incentives∗
We consider a 2-period model in which buyers can store the good by purchasing in advance of consumption so as to realize potential gains from inter-temporal arbitrage. We find that storability introduces a kink in the aggregate period-1 demand. When supply is oligopolistic (quantity setting) and consumers are sufficiently patient (storage cost is relatively low) then each firm has a strong curr...
متن کاملIncentives, Project Choice and Dynamic Multitasking* (Job Market Paper)
I study the optimal choice of investment projects in a continuous-time moral hazard model with multitasking. While in the first best, projects are invariably chosen by the net present value (NPV) criterion, moral hazard introduces a cutoff for project selection which depends on both a project’s NPV as well as its risk-return ratio. The cutoff shifts dynamically depending on the past history of ...
متن کاملDynamic analysis of various investment incentives and regional capacity assignment in Iranian electricity market
This paper develops a system dynamics model to analyze the impacts of different kinds of capacity payment as investment incentive mechanisms in Iranian electricity market. Since it is aimed that the incurred capital and operating costs of generation technologies be recovered in Iranian electricity pool, the noncompetitive capacity payment mechanism has been introduced for this purpose in order ...
متن کاملMarket incentives and pharmaceutical innovation.
I study the impact of the Orphan Drug Act (ODA), which established tax incentives for rare disease drug development. I examine the flow of new clinical drug trials for a large set of rare diseases. Among more prevalent rare diseases, the ODA led to a significant and sustained increase in new trials. The impact for less prevalent rare diseases was limited to an increase in the stock of drugs. Ta...
متن کاملذخیره در منابع من
با ذخیره ی این منبع در منابع من، دسترسی به آن را برای استفاده های بعدی آسان تر کنید
ژورنال
عنوان ژورنال: Journal of Optimization Theory and Applications
سال: 2005
ISSN: 0022-3239,1573-2878
DOI: 10.1007/s10957-005-2659-0